FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Lagan Seamus
   2. Issuer Name and Ticker or Trading Symbol
Rennova Health, Inc. [RNVA] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
CEO and President
(Last)
(First)
(Middle)
400 S. AUSTRALIAN AVE., SUITE 800		 3. Date of Earliest Transaction (Month/Day/Year)
07/17/2016
(Street)

WEST PALM BEACH,, FL 33401		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/17/2016   A   333,334 A $ 0.3 344,234 D  
Common Stock 07/25/2016   J(1)   333,334 A $ 0.3 (1) 755,261 I By: Alcimede LLC
Common Stock 08/05/2016   J(2)   1,171,667 A $ 0.3 (2) 1,926,928 I By: Alcimede LLC

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options to Purchase Common Stock $ 0.3 07/17/2016   A   250,000   07/17/2016 07/17/2026 Common Stock 250,000 $ 0 250,000 D  
Options to Purchase Common Stock $ 0.3 07/17/2016   A   250,000   12/31/2016 07/17/2026 Common Stock 250,000 $ 0 250,000 D  
Options to Purchase Common Stock $ 0.3 07/17/2016   A   250,000   12/31/2017 07/17/2026 Common Stock 250,000 $ 0 250,000 D  
Options to Purchase Common Stock $ 0.3 07/17/2016   A   250,000   12/31/2018 07/17/2026 Common Stock 250,000 $ 0 250,000 D  
Options to Purchase Common Stock $ 0.3 07/17/2016   A   500,000     (3) 07/17/2026 Common Stock 500,000 $ 0 500,000 D  
Options to Purchase Common Stock $ 0.3 07/17/2016   A   500,000     (4) 07/17/2026 Common Stock 500,000 $ 0 500,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Lagan Seamus
400 S. AUSTRALIAN AVE., SUITE 800
WEST PALM BEACH,, FL 33401		   X   X   CEO and President  
Alcimede LLC
400 S. AUSTRALIAN AVE., SUITE 800
WEST PALM BEACH,, FL 33401		       Affiliated

Signatures

 /s/ Seamus Lagan   09/14/2016
**Signature of Reporting Person Date
 Alcimede LLC By: /s/ Seamus Lagan, Sole Manager   09/14/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Alcimede LLC received the shares in lieu of a $100,000 cash payment for services rendered.
(2) Alcimede LLC received the shares in exchange for the cancellation of outstanding debt.
(3) The options become first exercisable upon the Issuer attaining $75 million in gross revenue in any of the Issuer's three fiscal years from the date of grant through December 31, 2018.
(4) The options become first exercisable upon the Issuer attaining a $100 million market capitalization at any time during the three year period ending July 17, 2019.
 
Remarks:
Exhibit List - Exhibit 99 - Joint Filer Information

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.